{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:15:43Z","timestamp":1778566543809,"version":"3.51.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Sepsis-associated acute kidney injury (SA-AKI) is common in critically ill patients and carries high short-term mortality despite timely antimicrobials and organ support. Adsorptive hemofilters such as the oXiris\n                      <jats:sup>\u00ae<\/jats:sup>\n                      membrane have been proposed as adjuncts during continuous renal replacement therapy (CRRT), but their patient-centered benefit remains uncertain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a retrospective matched cohort study within a dynamic cohort of consecutive adults with septic shock and SA-AKI requiring CRRT in a tertiary ICU in Medell\u00edn, Colombia (November 2020 - May 2023). Exposure was the hemofilter used at CRRT initiation (oXiris\n                      <jats:sup>\u00ae<\/jats:sup>\n                      vs standard AN69ST). Patients were matched 2:1 without replacement using nearest-neighbor propensity scores based on age, Sequential Organ Failure Assessment (SOFA) score at ICU admission, time from ICU admission to CRRT initiation, and infection source. The primary outcome was 28-day all-cause mortality from ICU admission. Secondary outcomes included ventilator-free days and ICU\u2013free days at day 28, CRRT duration, and ICU length of stay. Prespecified sensitivity analyses excluded COVID-19 cases and used inverse probability of treatment weighting (IPTW). Exploratory analyses assessed early changes in SOFA, lactate, PaO2\/FiO2, mean arterial pressure, vasopressor dose, and C-reactive protein.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After matching, 81 patients were included (53 standard filters and 28 oXiris\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ); 3 oXiris\n                      <jats:sup>\u00ae<\/jats:sup>\n                      - patients were unmatched. Twenty-eight-day mortality was 69.8% (37\/53) with standard filters and 67.9% (19\/28) with oXiris\n                      <jats:sup>\u00ae<\/jats:sup>\n                      . The adjusted risk ratio (RR) for oXiris\n                      <jats:sup>\u00ae<\/jats:sup>\n                      was 0.95 (95% CI, 0.71-1.28; P\u00a0=\u00a00.76), with an absolute risk difference of -2.0% (95% CI, -23.2% to 19.3%). After excluding COVID-19 cases (n = 61), the adjusted RR was 1.05 (95% CI, 0.71-1.54; P\u00a0=\u00a00.81). IPTW analyses were directionally similar but considered secondary. Early physiologic changes showed no clear between-group differences.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In adults with septic shock and SA-AKI requiring CRRT, oXiris\n                      <jats:sup>\u00ae<\/jats:sup>\n                      use was not associated with lower 28-day mortality compared with standard AN69ST filters. Secondary and exploratory finding should be interpreted cautiously given residual confounding and data limitations. Randomized trials with standardized protocols are needed to identify potential benefiting subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneph.2026.1810007","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:44:29Z","timestamp":1778564669000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of oXiris\u00ae vs standard AN69ST filters in sepsis-associated acute kidney injury requiring continuous renal replacement therapy: a retrospective matched cohort study"],"prefix":"10.3389","volume":"6","author":[{"given":"David","family":"Yepes G\u00f3mez","sequence":"first","affiliation":[{"name":"Critical Care Physician, Department Head, Victoriana Clinic, Intensivist, Cl\u00ednica Las Am\u00e9ricas","place":["Medell\u00edn, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Moreno-Bedoya","sequence":"additional","affiliation":[{"name":"Postgraduate in Epidemiology, Anesthesiology resident, Faculty of Medicine, Universidad CES","place":["Medell\u00edn, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"Lohle-Rueda","sequence":"additional","affiliation":[{"name":"Master of Business Administration (MBA) candidate, Faculty of Medicine, Universidad del Rosario","place":["Bogot\u00e1, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Rodrigo","family":"Moreno-Restrepo","sequence":"additional","affiliation":[{"name":"Critical Care specialist, Critical Care Unit coordinator, Cl\u00ednica CES","place":["Medell\u00edn, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Palacio-Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"General Practitioner, High Dependency Unit, Cl\u00ednica CES","place":["Medell\u00edn, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"G\u00f3mez-Correa","sequence":"additional","affiliation":[{"name":"General Practitioner, High Dependency Unit, Cl\u00ednica CES","place":["Medell\u00edn, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sierra Ramirez","sequence":"additional","affiliation":[{"name":"Anesthesiology resident, Faculty of Medicine, Universidad CES","place":["Medell\u00edn, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Camila","family":"Salazar Agudelo","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology resident, Faculty of Medicine, Universidad de Cartagena","place":["Cartagena, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Villegas-Arbel\u00e1ez","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology, Health Research Lead, Cl\u00ednica CES","place":["Medell\u00edn, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital-and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations","volume":"193","author":"Fleischmann","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit Care Lond Engl"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1159\/000499589","article-title":"Continuous renal replacement therapy with the adsorbing filter oXiris in septic patients: a case series","volume":"47","author":"Turani","year":"2019","journal-title":"Blood Purif"},{"key":"B6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000500013","article-title":"What have we learned about the use of Cytosorb adsorption columns","volume":"48","author":"Ankawi","year":"2019","journal-title":"Blood Purif"},{"key":"B7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/MCC.0000000000000542","article-title":"An update on membranes and cartridges for extracorporeal blood purification in sepsis and septic shock","volume":"24","author":"Honor\u00e9","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"B8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000499510","article-title":"oXiris\u00ae use in septic shock: experience of two French centres","volume":"47","author":"Schwindenhammer","year":"2019","journal-title":"Blood Purif"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00451-3","article-title":"Extracorporeal haemoadsorption: does the evidence support its routine use in critical care","volume":"10","author":"Supady","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13054-022-04009-w","article-title":"Hemoperfusion: technical aspects and state of the art","volume":"26","author":"Ronco","year":"2022","journal-title":"Crit Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40635-018-0177-2","article-title":"In vitro comparison of the adsorption of inflammatory mediators by blood purification devices","volume":"6","author":"Malard","year":"2018","journal-title":"Intensive Care Med Exp"},{"key":"B12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13054-023-04555-x","article-title":"Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis","volume":"27","author":"Wang","year":"2023","journal-title":"Crit Care"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5935\/0103-507X.20140059","article-title":"Septic versus non-septic acute kidney injury in critically ill patients: characteristics and clinical outcomes","volume":"26","author":"Cruz","year":"2014","journal-title":"Rev Bras Ter Intensiva"},{"key":"B15","article-title":"R: A Language and Environment for Statistical Computing","year":"2025"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"B17","article-title":"Por La Cual Se Establecen Las Normas Cient\u00edficas, T\u00e9cnicas Y Administrativas Para La Investigaci\u00f3n En Salud","year":"1993"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04588-2","article-title":"Comment on: Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis","volume":"27","author":"Huang","year":"2023","journal-title":"Crit Care Lond Engl"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000547587","article-title":"Interleukin-6 removal and clinical effects of Oxiris: a systematic review and meta-analysis","volume":"28","author":"Ulsamer","year":"2025","journal-title":"Blood Purif"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.107994","article-title":"Comparing adsorptive blood purification modalities for sepsis patients: a systematic review and network meta-analysis","volume":"239","author":"Xing","year":"2025","journal-title":"Respir Med"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1810007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:44:30Z","timestamp":1778564670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1810007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":20,"alternative-id":["10.3389\/fneph.2026.1810007"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2026.1810007","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"article-number":"1810007"}}